bioAffinity Technologies logo
bioAffinity Technologies
BIAF | NASDAQ
Chart Builder DCF Calculator
$2.00
-$0.20 (-9.09%)
At close: Nov 16, 2026, 4:00 PM ET
$2.10
+$0.10 (+5.00%)
After-hours: Nov 16, 2026, 7:34 PM ET

bioAffinity Technologies Company Profile

Company profile explained

Company Profile

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.

Key Executives

Name Position
Maria Zannes Founder, President, Chief Executive Officer & Director
James Michael Edwards Chief Financial Officer
Xavier T. Reveles Chief Operating Officer
Dallas J. Coleman Vice President of sales
Gordon Downie Chief Medical Officer
Julie Anne Overton Director of Communications
Steven Girgenti Founder & Executive Chairman of the Board
Timothy Zannes Executive Vice President, Secretary & General Counsel
William Bauta Chief Science Officer

Latest SEC Filings

Date Type Title
Oct 29, 2026 8-K Current Report
Oct 23, 2026 DEF 14A Filing
Oct 15, 2026 8-K Current Report
Oct 13, 2026 8-K Current Report
Oct 13, 2026 PRER14A Filing
Oct 09, 2026 8-K Current Report
Oct 09, 2026 424B5 Filing
Oct 09, 2026 424B5 Filing
Oct 08, 2026 8-K Current Report
Oct 06, 2026 8-K Current Report
View All SEC Filings ➞
bioAffinity Technologies
bioAffinity Technologies logo
Country United States
IPO Date Sep 1, 2022
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 57
CEO Maria Zannes

Contact Details

3300 Nacogdoches Road San Antonio, Texas 78217 United States

Stock Details

Ticker Symbol BIAF
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001712762
CUSIP Number 09076W406
ISIN Number US09076W4069
SIC Code 8731

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.